Dario

PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company" or "Dario"), a leader in the global digital therapeutics (DTx) market, announced today that.

Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. These options are being issued pursuant to Nasdaq Listing Rule 5635(c)(4) and are outside of the Company's existing equity compensation plans. I believe Dario is very well positioned to be a leader in the space, and I look forward to contributing to our future success." Shay was granted a non-qualified stock option award to purchase 100,000 shares of the Company's common stock, as well as an additional non-qualified performance-based stock option award to purchase an additional 80,000 shares of the Company's common stock. Statements that are not statements of historical fact may be deemed to be forward-looking statements. [DRIO](#financial-modal)) (the "Company" or "Dario"), a leader in the global digital therapeutics (DTx) market, announced today that digital health veteran, Eitan Shay, is joining the Company in the newly created position of Chief Product Officer. "Having worked in digital health for the past several years, I am impressed with both the pace and success of Dario's transformation to become a leading multi-chronic condition platform that provides a seamless and highly engaging user experience," stated Mr. Our user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. "I could not be more excited to welcome Eitan to the Dario team, as his unique background offers a combination of experience in high-growth commercial product environments along with a deep understanding of consumer engagement. "Demand for our solution continues to accelerate among payers and employers, and the ability to enhance and scale our intelligent platform is central to our growth strategy," stated Erez Raphael, Chief Executive Officer of Dario.